GOLDEN, CO / ACCESSWIRE / April 27, 2021 / Vitro Biopharma Inc. (formerly Vitro Diagnostics Inc.) (dba Vitro Biopharma), announced its quarter ended January 31st, 2021, financial results of operations. Vitro Biopharma recorded quarter ended January 31st, 2021 revenues of $ 127,492 vs $225,921 a decrease of 44% over the prior comparative quarter directly attributed to the COVID-19 pandemic
MIAMI, April 27, 2021 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing cellular therapies for chronic, aging-related and life-threatening conditions, announces it has been selected to present at the 2021 World Stem Cell Summit taking place virtually on June 14-18, in combination with the Wake Forest Institute for Regenerative Medicine (WFIRM) and Regenerative Medicine Foundation (RMF). Dr.
This article was originally published here Sheng Li Xue Bao. 2021 Apr 25;73(2):181-196. ABSTRACT Organoids are self-organized cellular clusters in three-dimensional culture, which can be derived from a single stem cell, progenitor or cell clusters of different lineages resembling in vivo tissue architecture of an organ
Our ability to use cellular therapies to treat acute leukemias is expanding, said Grunwald.
URBANA, Ill., April 26, 2021 /PRNewswire/ -- A team from the University of Illinois Urbana-Champaign's Grainger College of Engineering and Mayo Clinic have developed a new technique for creating "microcancer" cell cultures.
President Joe Biden departs church after the confirmation of his grandson Hunter at St. Joseph on the Brandywine Catholic Church in Greenville, Del., April 18, 2021. (CNS photo/Kevin Lamarque, Reuters) Apr
The Global Stem Cell Therapy for Diabetes and Related Conditions Market Research Report 2021-2025 is a significant source of keen information for business specialists. A report published by Market Insights Reports is an overall investigation and thorough information in regards to the market size and market elements of the Stem Cell Therapy for Diabetes and Related Conditions
In 2009, Time magazine declared cultured meat one of their top 50 inventions of the year for its potential to curb the carbon footprint of industrial farming. This promising idea has since become a booming industry.
TheCanine Stem Cell Therapy Market sizewas valued atUS$ 118.5 Mn in 2018and is expected to grow at a compound annual growth rate (CAGR) of9.3%for the forecast period ending2026 reaching a Market value of US$ 240.7 Mn.in this research study the industry developments with key trends and marketing channels are analyzed with the feasibility of new investment projects is assessed, and overall research conclusions offered. In addition, Porters Five Forces research provides the economic climate of the industry, which is covered in the Canine Stem Cell Therapy business review. The study focuses on market share and competition index analysis, which aids in determining the leading players contribution to the Canine Stem Cell Therapy business
The Recombinant Cell Culture Supplements Market report by Persistence Market Research is focusing on the fact that healthcare providers are into collection of socioeconomic information of the patients, so that tracking at any point of time is possible.
Recent Comments